Ixabepilone Plus Capecitabine for Metastatic Breast Cancer Progressing After Anthracycline and Taxane TreatmentE. Donnall Thomas, Henri Roché, Henry Gómez et al.|Journal of Clinical Oncology|2007Cited by 483
Ki67 Expression and Docetaxel Efficacy in Patients With Estrogen Receptor–Positive Breast CancerFrédérique Penault‐Llorca, Henri Roché|Journal of Clinical Oncology|2009Cited by 238
Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, As First-Line Therapy in Patients With Metastatic Breast Cancer Previously Treated With Anthracycline ChemotherapyHenri Roché, Hervé Curé, Louise Yelle et al.|Journal of Clinical Oncology|2007Cited by 225
Phase II Study of the Halichondrin B Analog Eribulin Mesylate in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline, a Taxane, and CapecitabineJavier Cortés, Mary Ann Allison, Linda T. Vahdat et al.|Journal of Clinical Oncology|2010Cited by 217
Sorafenib in Combination With Capecitabine: An Oral Regimen for Patients With HER2-Negative Locally Advanced or Metastatic Breast CancerJosé Baselga, Frederico Costa, Antonio Llombart‐Cussac et al.|Journal of Clinical Oncology|2012Cited by 163